Medicare's hospital compare performance measures and mortality rates [3]

JAMA

Volumn 297, Issue 13, 2007, Pages 1430-

  Fierer, Joshua ^a  

^a VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT;

ANTIBIOTIC THERAPY; CLOSTRIDIUM DIFFICILE; COLITIS; COMPARATIVE STUDY; EMERGENCY WARD; HEALTH CARE POLICY; HEALTH CARE QUALITY; HOSPITAL; HUMAN; LETTER; MEDICARE; MORTALITY; OUTCOME ASSESSMENT; PNEUMONIA; PRACTICE GUIDELINE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; THERAPY DELAY; EPIDEMIOLOGY; METHODOLOGY; NOTE; QUALITY CONTROL; STANDARD; TREATMENT OUTCOME; UNITED STATES;

BENCHMARKING; BIAS (EPIDEMIOLOGY); HOSPITAL MORTALITY; HOSPITALS; HUMANS; MEDICARE; OUTCOME AND PROCESS ASSESSMENT (HEALTH CARE); QUALITY INDICATORS, HEALTH CARE; RESEARCH DESIGN; UNITED STATES;

EID: 34147093310     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: None     Document Type: Letter

References (4)

1. Werner RM, Bradlow ET. Relationship between Medicare's Hospital Compare performance measures and mortality rates [published correction appears in JAMA. 2007;297:700]. JAMA. 2006;296:2694-2702.
2. Houck PM, Bratzler DW, Nsa W, Bartlett JG. Timing of antibiotic administration and outcomes for Medicare patients hospitalized with community acquired pneumonia. Arch Intern Med. 2004;164:637-644.
3. Musher DM, Montoya R, Wanahita A. Diagnostic value of microscopic examination of Gram-stained sputum and sputum cultures in patients with bacteremic pneumococcal pneumonia. Clin Infect Dis. 2004;39:165-169.
4. McCusker ME, Harris AD, Perencevich E, Roghmann MC. Fluoroquinolone use and Clostridium difficile-associated diarrhea. Emerg Infect Dis. 2003;9:730-733.